Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™
The AYON Body Contouring System is the first FDA cleared all-in-one platform for the aesthetic surgical suite Plan to initiate...
Day: May 13, 2025
CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
- Updated BOND-003 clinical results presented at AUA showing best-in-disease durability and tolerability data for Cohort C with 24-month complete...
Remedy Plan Therapeutics Raises $18 Million Financing to Accelerate Advancement of Lead Asset RPT1G into Phase 1/2 Trials
Financing includes participation from Schooner Capital, Alexandria Venture Investments, and other existing investorsInvestment accelerates advancement of RPT1G, a novel NAMPT...
Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit
WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical...
KNoW Biological Receives FDA Breakthrough Device Designation
Atlanta-based firm to begin clinical trial on advanced warning seizure monitor ATLANTA, May 13, 2025 /PRNewswire/ -- KNoW Biological has...
Wincomm Wins Best Choice Award at COMPUTEX 2025 for AI-Driven Surgical Panel PC
HSINCHU, May 13, 2025 /PRNewswire/ -- Wincomm, a global leader in medical-grade computing solutions, has been awarded the Best Choice...
Fangzhou CEO Honored at 2025 VBEF Conference as Company Showcases AI Medical Innovations
SUZHOU, China, May 13, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, participated...
For Labbit, Semaphore Solutions Recognized in the Gartner® Market Guide for Laboratory Information Management Systems
VICTORIA, BC, May 13, 2025 /PRNewswire/ - Semaphore Solutions, a leading provider of laboratory informatics platforms, announced today that for...
GI Innovation and GI Biome Advance to the Semi-finals of XPRIZE Healthspan with Anti-Aging Potential of GI-102 and GIB-7 Combination Therapy
GI Innovation and GI Biome have been selected as a Top 40 semi-finalist in the XPRIZE Healthspan competition among 600 registered teams from 58...